Arrow Greentech grants 61,000 options at ₹359
Arrow Greentech granted 61,000 ESOPs at ₹359 each under its 2024 scheme. Options vest after one year and are exercisable for three years from the vesting date.

*this image is generated using AI for illustrative purposes only.
Arrow Greentech has granted 61,000 employee stock options to eligible employees under its ESOP Scheme 2024. The decision was approved by the company's Nomination and Remuneration Committee. The options are granted in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits) Regulations, 2021.
Key Details of the Grant
The options granted are exercisable into an equal number of fully paid-up equity shares with a face value of ₹10 each. The exercise price has been fixed at ₹359 per option. The grant follows the provisions of the Arrow Greentech ESOP Scheme - 2024.
Vesting and Exercise Schedule
The options come with a vesting period of a minimum of one year from the date of grant. All options granted will vest according to the schedule specified in the respective grant letters. Once vested, the options can be exercised within a period of three years from the date of vesting.
| Particulars | Details |
|---|---|
| Total Options Granted | 61,000 |
| Exercise Price | ₹359 per option |
| Face Value | ₹10 per share |
| Vesting Period | Minimum 1 year |
| Exercise Period | 3 years from vesting |
The company stated that there are no variations in the terms of the options, and no options have lapsed or been exercised at this stage. The grant is part of the company's employee benefit initiatives to align the interests of employees with those of the shareholders.
Historical Stock Returns for Arrow Greentech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.47% | -1.45% | -11.17% | -12.52% | -25.16% | +300.17% |
How might the ₹359 exercise price compare to Arrow Greentech's future stock performance, and will employees likely benefit from exercising these options when the vesting period concludes?
Could Arrow Greentech's ESOP Scheme 2024 signal plans for further talent acquisition or retention initiatives, and are additional option grants expected in the near future?
How will the potential dilution from 61,000 new equity shares impact existing shareholders' ownership percentage and the company's earnings per share metrics?


































